| Literature DB >> 27721499 |
Liliang Guo1,2, Zhenghong Sui1, Yuan Liu1.
Abstract
Miseq sequencing and data analysis for the actin gene and v9 region of 18S rDNA of 7 simulated samples consisting of different mixture of dinoflagellates and diatoms were carried out. Not all the species were detectable in all the 18S v9 samples, and sequence percent in all the v9 samples were not consistent with the corresponding cell percent which may suggest that 18S rDNA copy number in different cells of these species differed greatly which result in the large deviation of the amplification. And 18S rDNA amplification of the microalgae was prone to be contaminated by fungus. The amplification of actin gene all was from the dinoflagellates because of its targeted degenerate primers. All the actin sequences of dinoflagellates were detected in the act samples except act4, and sequence percentage of the dinoflagellates in the act samples was not completely consistent with the dinoflagellates percentage of cell samples, but with certain amplification deviations. Indexes of alpha diversity of actin gene sequencing may be better reflection of community structure, and beta diversity analysis could cluster the dinoflagellates samples with identical or similar composition together and was distinguishable with blooming simulating samples at the generic level. Hence, actin gene was more proper than rDNA as the molecular marker for the community analysis of the dinoflagellates.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27721499 PMCID: PMC5056376 DOI: 10.1038/srep34709
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Generic composition of the 9 samples for the actin (a) and 18S v9 (b) sequencing.
Figure 2Percent compositions of the sequences and the cells in the 9 samples for the actin (a) and 18S v9 (b–d) (numbers next to the scatter plots are the number of the samples).
The deviation and sequence percent/cell percent of the genera for actin and 18S v9 sequencing.
| Genus | seq percent/cell percent | Deviation | SD |
|---|---|---|---|
| For | |||
| 0.6806–3.3078 | 0.39 | ±0.8811 | |
| 0.9718–3.1823 | 0.682 | ±0.8272 | |
| 0.0133–1.4811 | −0.58 | ±0.4851 | |
| 0.069–1.5656 | −0.316 | ±0.5144 | |
| 0.0218–0.0707 | −0.963 | ±0.019 | |
| For 18S v9 sequencing samples | |||
| 0.001~42.214 | 13.073 | ±24.3707 | |
| 0.036~10.095 | 0.497 | ±3.4977 | |
| 0.036~16.152 | 2.519 | ±7.081 | |
| −0.775~10008.5 | 1205.571 | ±3311.9429 | |
| 0.0086~3.5776 | 0.7931 | ±2.5237 | |
| 0.12~163.539 | 40.351 | ±81.4596 | |
| 0.596~4.038 | 1.317 | ±2.4337 | |
| 0.04~10.095 | 1.29 | ±4.3749 | |
| −0.785~106.007 | 23.335 | ±46.3827 | |
| −0.9312~5.057 | 1.407 | ±2.8708 | |
| 0.1376~2.019 | 0.0783 | ±1.3304 | |
| −0.9656~49.475 | 9.727 | ±22.2541 | |
Figure 3The Rarefaction Curve of the actin (a) and 18S v9 (b) samples.
Figure 4The UPGMA Bray-Curtis tree of the actin (a) and 18S v9 (b) sequencing samples.